TGEN http://www.tgen.org/news/index.cfm?pageid=842 Prostate Cancer is a deadly disease that took the lives of nearly 31,000 American men in 2001. It is estimated that more than 230,000 new cases will be diagnosed in 2004. Prostate cancer is the most common cancer and the second leading cause of cancer death in men. Researchers at TGen are focused on searching for genetic identifiers that will act as predictors for prostate cancer. TGen is currently conducting the most in-depth study of its kind designed to scan the genomes of 112 families with prostate cancer to identify genetic risk factors for the disease. Prostate Cancer is a deadly disease that took the lives of nearly 31,000 American men in 2001. It is estimated that more than 230,000 new cases will be diagnosed in 2004. Prostate cancer is the most common cancer and the second leading cause of cancer death in men. Researchers at TGen are focused on searching for genetic identifiers that will act as predictors for prostate cancer. TGen is currently conducting the most in-depth study of its kind designed to scan the genomes of 112 families with prostate cancer to identify genetic risk factors for the disease. no Genomics Research en-us Copyright TGen 2009 Mon, 11 May 2009 08:00:00 PST http://public.tgen.org/tgen.org/downloads/podcast/PROSTATECANCER_VIDEO.mp4 news@tgen.org Prostate Cancer is a deadly disease that took the lives of nearly 31,000 American men in 2001. It is estimated that more than 230,000 new cases will be diagnosed in 2004. Prostate cancer is the most common cancer and the second leading cause of cancer death in men. Researchers at TGen are focused on searching for genetic identifiers that will act as predictors for prostate cancer. TGen is currently conducting the most in-depth study of its kind designed to scan the genomes of 112 families with prostate cancer to identify genetic risk factors for the disease. Mon, 11 May 2009 08:00:00 PST 00:03:02